Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cancer discovery

Showing results (701-710 of 4,679) with videos related to

Pageof 468
Sort By:
Cancer Discovery|January 20, 2023
Blood-Borne Myeloid Cell Loss of MHCII Drives Cytotoxic T-cell Dysfunction
Cancer Discovery|January 20, 2023
A Trifunctional Natural Killer Cell Engager Can Target CD123+ Leukemia
Cancer Discovery|January 20, 2023
Genomic Instability and Protumoral Inflammation Are Associated with Primary Resistance to Anti-PD-1 + Antiangiogenesis in Malignant Pleural MesotheliomaFrançois-Xavier Danlos, Matthieu Texier, Bastien Job, et al.
Cancer Discovery|January 26, 2023
Survivors of Pediatric HL May Age More Quickly
Cancer Discovery|January 13, 2023
A Whole Cancer Cell-Based Vaccine Boosts Cell Killing and Antitumor Immunity
Cancer Discovery|January 6, 2023
Altered tRNA Isoacceptor Abundance Regulates Breast Cancer Metastasis
Cancer Discovery|January 6, 2023
IL7 Genetic Variation Predicts Immune-Related Adverse Events
Cancer Discovery|January 6, 2023
Targeting RNA Splicing Overcomes Leukemia Resistance to BCL2 Inhibition
Cancer Discovery|July 1, 2021
Tumor Microenvironment-Derived R-spondins Enhance Antitumor Immunity to Suppress Tumor Growth and Sensitize for Immune Checkpoint Blockade TherapyYuting Tang, Qian Xu, Liang Hu, et al.
Cancer Discovery|June 24, 2021
AI Pinpoints Origin of Unidentified Cancers
Pageof 468

Showing results (701-710 of 4,679) with videos related to

Sort By:
Pageof 468
Cancer Discovery|January 20, 2023
Blood-Borne Myeloid Cell Loss of MHCII Drives Cytotoxic T-cell Dysfunction
Cancer Discovery|January 20, 2023
A Trifunctional Natural Killer Cell Engager Can Target CD123+ Leukemia
Cancer Discovery|January 20, 2023
Genomic Instability and Protumoral Inflammation Are Associated with Primary Resistance to Anti-PD-1 + Antiangiogenesis in Malignant Pleural MesotheliomaFrançois-Xavier Danlos, Matthieu Texier, Bastien Job, et al.
Cancer Discovery|January 26, 2023
Survivors of Pediatric HL May Age More Quickly
Cancer Discovery|January 13, 2023
A Whole Cancer Cell-Based Vaccine Boosts Cell Killing and Antitumor Immunity
Cancer Discovery|January 6, 2023
Altered tRNA Isoacceptor Abundance Regulates Breast Cancer Metastasis
Cancer Discovery|January 6, 2023
IL7 Genetic Variation Predicts Immune-Related Adverse Events
Cancer Discovery|January 6, 2023
Targeting RNA Splicing Overcomes Leukemia Resistance to BCL2 Inhibition
Cancer Discovery|July 1, 2021
Tumor Microenvironment-Derived R-spondins Enhance Antitumor Immunity to Suppress Tumor Growth and Sensitize for Immune Checkpoint Blockade TherapyYuting Tang, Qian Xu, Liang Hu, et al.
Cancer Discovery|June 24, 2021
AI Pinpoints Origin of Unidentified Cancers
Pageof 468